Mounjaro Enters India Eli Lilly, the American pharmaceutical giant, announced the launch of its diabetes and weight-loss treatment, Mounjaro (tirzepatide), in India. With approval from India’s Central Drugs Standard Control… Continue Reading
Medicine Prices Increasing from April 1: Patients to Pay More for Essential Drugs
NPPA Approves 1.7% Hike on Essential Drug Prices: What Patients Need to Know New Delhi, March 28, 2025 – Starting April 1, 2025, many of patients across India will face… Continue Reading
Rising Interest of International Patients for Cancer Treatment in India
Cancer is a devastating disease that is affecting millions of people globally. Moreover, it drains patients physically and financially. Recently, India has emerged as a hub for medical tourism and… Continue Reading
GST Reduction on Cancer Drugs to Enhance Patient Access
The 54th GST Council meeting, chaired by Finance Minister Nirmala Sitharaman, has approved a reduction in GST rates from 12% to 5% for three cancer drugs: trastuzumab deruxtecan, osimertinib, and… Continue Reading
New Treatment Regimen for Multi-Drug-Resistant TB Approved
The Indian government has approved a new, shorter treatment for multi-drug-resistant tuberculosis (MDR-TB). This new regimen, called BPaLM, combines four drugs: Bedaquiline, Pretomanid, Linezolid, and optionally Moxifloxacin. It can cure… Continue Reading